Cambridge Healthtech Institute’s Seventh Annual

Personalized Diagnostics

Establishing Clinical Sequencing as a Routine Diagnostic Tool

March 7 – 9, 2016 | Moscone North Convention Center | San Francisco, CA
Part of the 23rd International Molecular Medicine Tri-Conference

 

This year, we will investigate subjects of controversy in the implementation of next-generation sequencing for routine clinical use. This includes deciphering driver mutations, determining when to sequence tumor DNA, using matched controls, evaluating and validating exome sequencing for routine diagnosis, profiling DNA to overcome tumor resistance and heterogeneity, weighing uses of tissue biopsy vs. cell-free DNA, and factoring in cost. The Personalized Diagnostics conference promises to be a dynamic interchange of ideas and advances impacting the field.

Who should attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Diagnostic and Healthcare companies, Pharma, Biotechs and Academia working in fields of Diagnostics, Business Development, R&D, Chemistry, Clinical Research, in vitro Diagnostics, Personalized Healthcare, Process Development, and Oncology.

Topics will include, but are not limited to: 

  • Changing guidelines on who will regulation the use of NGS for diagnostics
  • Reviewing the use of tumor-only sequencing vs. matched control
  • Overcoming difficulties in benchmarking somatic genetic variants in cancer
  • Translating circulating biomarkers into clinical use
  • Advancing prenatal molecular diagnostics
  • Applying driver mutations to tumor heterogeneity and resistance
  • Preparing exome sequencing for molecular diagnosis
  • Understanding Big Data’s role in enabling personalized medicine

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is August 7, 2015. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Christina Lingham
Executive Director, Conferences
Cambridge Healthtech Institute
T: 781-972-5464
E: clingham@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca (Companies L-Z)
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com 

Premier Sponsors:   

Elsevier    

Jackson Laboratory - small logo  

 NanoString2    

 Precision for Medicine 

SeraCare 

Silicon Biosystems 

Thomson Reuters-Large